Roche to Team with CapitalBio on MDx Applications

Roche and CapitalBio intend to develop molecular diagnostics applications using microarray and potentially next-generation sequencing technologies.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.